EntrepreneurshipInnovationInvestmentsMedicalNewsfeed Cannabis Chewing Gum for Multiple Sclerosis in Development AXIM Biotechnologies and its partner Quay Pharmaceuticals have obtained the necessary licenses to move forward with the development of a.. 9 May